| Name | chromosome 4 open reading frame 54 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Recent studies have highlighted the potential importance of poorly characterized genes encoded on chromosome 4 in human disease. For instance, large‐scale gene expression profiling in rheumatoid arthritis revealed numerous differentially expressed transcripts – including several novel candidates – that may play roles in cellular structure and disease pathogenesis (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Similarly, in a study of Epstein–Barr virus–associated intrahepatic cholangiocarcinoma, distinct mutational patterns and an altered tumor immune microenvironment were identified, underscoring the diverse functional implications of chromosomally encoded genes in modulating both tumor behavior and host immune responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Most notably, however, a candidate gene located on chromosome 4 – later designated FOPV – was identified in patients with obliterative portal venopathy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " This gene, which corresponds to C4orf54, encodes a large protein of 1,793 amino acids that is predominantly expressed in intrahepatic portal veins. The identification of deleterious missense mutations in familial and non‐familial cases indicates that C4orf54 may be critical for maintaining portal venous integrity and proper vascular remodeling. Although its exact biological function remains to be fully deciphered, the collective evidence suggests that C4orf54 likely participates in the regulation of vascular structure and may have broader roles in disease contexts where altered gene expression or mutational profiles contribute to pathogenesis.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Alexander Platzer, Thomas Nussbaumer, Thomas Karonitsch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of gene expression in rheumatoid arthritis and related conditions offers insights into sex-bias, gene biotypes and co-expression patterns."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0219698"}], "href": "https://doi.org/10.1371/journal.pone.0219698"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31344123"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31344123"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yu-Hua Huang, Chris Zhi-Yi Zhang, Qun-Sheng Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jhep.2020.10.037"}], "href": "https://doi.org/10.1016/j.jhep.2020.10.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33212090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33212090"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Claude Besmond, Dominique Valla, Laurence Hubert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the novel gene FOPV are associated with familial autosomal dominant and non-familial obliterative portal venopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/liv.13547"}], "href": "https://doi.org/10.1111/liv.13547"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28792652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28792652"}]}]}]}
|
| NCBI Gene ID | 285556 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
C4ORF54 has 421 functional associations with biological entities spanning 3 categories (disease, phenotype or trait, chemical, gene, protein or microRNA) extracted from 6 datasets.
Click the + buttons to view associations for C4ORF54 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of C4ORF54 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with C4ORF54 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with C4ORF54 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of C4ORF54 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of C4ORF54 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of C4ORF54 gene from the RummaGEO Gene Perturbation Signatures dataset. | |